Findings show significant energy savings and no association with increased surgical site infection, mortality or ICU admission
Findings may help guide earlier AUD intervention
Implications for surgical decision-making and patient management
Patients have a significantly higher risk of developing fistulas and experiencing future Crohn’s-like changes
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Cleveland Clinic researchers developed an objective tool to assess response following total neoadjuvant therapy.
Patients may benefit from booster appointments, psychological support
Research demonstrates cirrhosis regression in one-third of patients, with higher rates using alternative assessment
Elevated risk persists for more than a year after surgery, plus more insights from the first study to quantify risk specifically for CRC surgery
Large, retrospective study indicates improved outcomes after one and five years of treatment
Retrospective analysis finds lower mortality rates, fewer hospital visits among patients with Type 1 diabetes using GLP-1 Therapies
Advertisement
Advertisement